The bioburden testing market presents opportunities driven by stringent regulations and the need for contamination control in pharma, biotech, and medical devices. Growth is expected in consumables and rapid testing instruments. North America leads due to reg… For the full story, visit the source.
Business
$4 Bn Bioburden Testing Markets, 2022-2024 & 2025-2032 - FDA/EMA Requirements, Rising Biosimilars Production and Advances in Rapid Microbial Detection Technologies Drive Adoption
The bioburden testing market presents opportunities driven by stringent regulations and the need for contamination control in pharma, biotech, and medical devices. Growth is expected in consumables and rapid testing instruments. North America leads due to reg…
By Research and Markets· GlobeNewswire· 5 months ago· 2 min read
This summary is sourced from GlobeNewswire. Read the full article at:GlobeNewswire